155 related articles for article (PubMed ID: 17435863)
1. [Prevalence of the use of anabolic agents among strength training apprentices in Porto Alegre, RS].
Silva PR; Machado LC; Figueiredo VC; Cioffi AP; Prestes MC; Czepielewski MA
Arq Bras Endocrinol Metabol; 2007 Feb; 51(1):104-10. PubMed ID: 17435863
[TBL] [Abstract][Full Text] [Related]
2. Anabolic-androgenic steroid use among Brazilian bodybuilders.
Nogueira FR; Brito Ade F; Oliveira CV; Vieira TI; Gouveia RL
Subst Use Misuse; 2014 Jul; 49(9):1138-45. PubMed ID: 24832911
[TBL] [Abstract][Full Text] [Related]
3. Brain nerve growth factor unbalance induced by anabolic androgenic steroids in rats.
Pieretti S; Mastriota M; Tucci P; Battaglia G; Trabace L; Nicoletti F; Scaccianoce S
Med Sci Sports Exerc; 2013 Jan; 45(1):29-35. PubMed ID: 22895368
[TBL] [Abstract][Full Text] [Related]
4. The anti-doping hot-line, a means to capture the abuse of doping agents in the Swedish society and a new service function in clinical pharmacology.
Eklöf AC; Thurelius AM; Garle M; Rane A; Sjöqvist F
Eur J Clin Pharmacol; 2003 Nov; 59(8-9):571-7. PubMed ID: 13680032
[TBL] [Abstract][Full Text] [Related]
5. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment.
Wesson DW; McGinnis MY
Pharmacol Biochem Behav; 2006 Mar; 83(3):410-9. PubMed ID: 16603236
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the use of anabolic-androgenic steroids in Brazil: a systematic review.
Abrahin OS; Sousa EC; Santos AM
Subst Use Misuse; 2014 Jul; 49(9):1156-62. PubMed ID: 24766401
[TBL] [Abstract][Full Text] [Related]
7. Human growth hormone abuse in male weightlifters.
Brennan BP; Kanayama G; Hudson JI; Pope HG
Am J Addict; 2011; 20(1):9-13. PubMed ID: 21175915
[TBL] [Abstract][Full Text] [Related]
8. Anabolic androgenic steroid-induced Takotsubo cardiomyopathy.
Placci A; Sella G; Bellanti G; Margheri M
BMJ Case Rep; 2015 Mar; 2015():. PubMed ID: 25804946
[TBL] [Abstract][Full Text] [Related]
9. [Anabolic androgenic steroids in amateur sports in the Netherlands].
Woerdeman J; de Hon O; Levi M; de Ronde WP
Ned Tijdschr Geneeskd; 2010; 154():A2004. PubMed ID: 20858322
[TBL] [Abstract][Full Text] [Related]
10. Nandrolone and stanozolol induce Leydig cell tumor proliferation through an estrogen-dependent mechanism involving IGF-I system.
Chimento A; Sirianni R; Zolea F; De Luca A; Lanzino M; Catalano S; Andò S; Pezzi V
J Cell Physiol; 2012 May; 227(5):2079-88. PubMed ID: 21769864
[TBL] [Abstract][Full Text] [Related]
11. Use of doping agents, particularly anabolic steroids, in sports and society.
Sjöqvist F; Garle M; Rane A
Lancet; 2008 May; 371(9627):1872-82. PubMed ID: 18514731
[TBL] [Abstract][Full Text] [Related]
12. Anabolic androgenic steroids--use and correlates among gym users--an assessment study using questionnaires and observations at gyms in the Stockholm region.
Leifman H; Rehnman C; Sjöblom E; Holgersson S
Int J Environ Res Public Health; 2011 Jul; 8(7):2656-74. PubMed ID: 21845151
[TBL] [Abstract][Full Text] [Related]
13. Current perspectives on anabolic-androgenic steroid abuse.
Lukas SE
Trends Pharmacol Sci; 1993 Feb; 14(2):61-8. PubMed ID: 8480376
[TBL] [Abstract][Full Text] [Related]
14. Rhabdomyolysis of the deltoid muscle in a bodybuilder using anabolic-androgenic steroids: a case report.
Farkash U; Shabshin N; Pritsch Perry M
J Athl Train; 2009; 44(1):98-100. PubMed ID: 19180225
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, West province of Iran.
Razavi Z; Moeini B; Shafiei Y; Bazmamoun H
J Res Health Sci; 2014; 14(2):163-6. PubMed ID: 24728754
[TBL] [Abstract][Full Text] [Related]
16. Anabolic ergogenic substance users in fitness-sports: a distinct group supported by the health care system.
Striegel H; Simon P; Frisch S; Roecker K; Dietz K; Dickhuth HH; Ulrich R
Drug Alcohol Depend; 2006 Jan; 81(1):11-9. PubMed ID: 16009506
[TBL] [Abstract][Full Text] [Related]
17. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem.
Melnik B; Jansen T; Grabbe S
J Dtsch Dermatol Ges; 2007 Feb; 5(2):110-7. PubMed ID: 17274777
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and Management of Anabolic Androgenic Steroid Use.
Anawalt BD
J Clin Endocrinol Metab; 2019 Jul; 104(7):2490-2500. PubMed ID: 30753550
[TBL] [Abstract][Full Text] [Related]
19. Psychiatric side effects induced by supraphysiological doses of combinations of anabolic steroids correlate to the severity of abuse.
Pagonis TA; Angelopoulos NV; Koukoulis GN; Hadjichristodoulou CS
Eur Psychiatry; 2006 Dec; 21(8):551-62. PubMed ID: 16356691
[TBL] [Abstract][Full Text] [Related]
20. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.
Socas L; Zumbado M; Pérez-Luzardo O; Ramos A; Pérez C; Hernández JR; Boada LD
Br J Sports Med; 2005 May; 39(5):e27. PubMed ID: 15849280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
